Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
D000818:Animals; D000956:Antigens, Viral; D000961:Antilymphocyte Serum; D002464:Cell Migration Inhibition; D002469:Cell Separation; D004926:Escherichia coli / Q000276:immunology; D017988:Gammaretrovirus / Q000276:immunology*; D007106:Immune Sera; D007074:Immunoglobulin G; D007165:Immunosuppression Therapy; D037102:Lectins; D007930:Leucine / Q000378:metabolism; D008070:Lipopolysaccharides; D008198:Lymph Nodes / Q000166:cytology; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D008297:Male; D051379:Mice; D011120:Polyomavirus / Q000276:immunology; D011135:Polysaccharides, Bacterial; D012513:Sarcoma, Experimental / Q000276:immunology*; D013154:Spleen / Q000166:cytology; D013601:T-Lymphocytes / Q000276:immunology*; D014020:Tissue Extracts; D014316:Tritium
D000956:Antigens, Viral; D000961:Antilymphocyte Serum; D007106:Immune Sera; D007074:Immunoglobulin G; D037102:Lectins; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D014020:Tissue Extracts; D014316:Tritium; D007930:Leucine